THE THERAPEUTIC USE OF BISPHOSPHONATES

被引：50

作者：

COMPSTON, JE

机构：

[1] Department of Medicine, University of Cambridge Clinical School, Addenbrooke's Hospital

来源：

BRITISH MEDICAL JOURNAL | 1994年 / 309卷 / 6956期

基金：

英国惠康基金;

关键词：

D O I：

10.1136/bmj.309.6956.711

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：711 / 715

页数：5

共 27 条

[11] 4-YEAR STUDY OF INTERMITTENT CYCLIC ETIDRONATE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS - 3 YEARS OF BLINDED THERAPY FOLLOWED BY ONE-YEAR OF OPEN THERAPY [J].

HARRIS, ST ;

WATTS, NB ;

JACKSON, RD ;

GENANT, HK ;

WASNICH, RD ;

ROSS, P ;

MILLER, PD ;

LICATA, AA ;

CHESNUT, CH .

AMERICAN JOURNAL OF MEDICINE, 1993, 95 (06) :557-567

[12]

Kanis J.A., 1991, PATHOPHYSIOLOGY TREA

[13]

MULDER H, 1994, BRIT J RHEUMATOL, V33, P348

[14] MECHANISMS OF OSTEOLYTIC BONE DESTRUCTION [J].

MUNDY, GR .

BONE, 1991, 12 :S1-S6

[15]

OTT SM, 1993, J BONE MINER RES, V8, pS597

[16]

OTT SM, 1990, OSTEOPOROSIS 1990, P1318

[17] THE USE OF BISPHOSPHONATES IN THE TREATMENT OF OSTEOPOROSIS [J].

PAPAPOULOS, SE ;

LANDMAN, JO ;

BIJVOET, OLM ;

LOWIK, CWGM ;

VALKEMA, R ;

PAUWELS, EKJ ;

VERMEIJ, P .

BONE, 1992, 13 :S41-S49

[18]

PATEL S, 1991, DRUGS, V46, P594

[19]

RALSTON SH, 1989, LANCET, V2, P1180

[20]

REGINSTER JY, 1989, LANCET, V2, P1469

← 1 2 3 →